OKYO Pharma Limited (OKYO) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

OKYO Pharma Limited (OKYO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $64.8M, listed on NASDAQ, employing roughly 3 people, carrying a beta of -0.05 to the broader market. OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Led by Robert J. Dempsey, public since 2022-05-17.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for OKYO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →